Air Purifiers Phoenix
The college’s program, also known as OLLI, received the $1 milliomn endowment from the BernardOsher Foundation, which is the organizatio n that has provided initial funding to OLLI programs at 122 college s and universities nationwide. Sierra College is the only communitt college in California and one of only three communityu colleges in the nation to receivethe $1 million endowment. The Rocklin college received the endowmenrt because it has been so successful with growing enrollment since launching the progranm in springof 2001. Sierra College has grown the programto 5,58p0 enrollees last year, from 1,039 in 2001. Sierra College is scheduled to formally announcew the endowmentJune 18.
This $1 million endowment will provides an ongoing budget that will enables the college to offer lifelong learninyg programsin perpetuity. The foundation createfd by San Francisco philanthropistg Bernard Osher gives OLLIprograms $100,000 a year for up to four and then a $1 million endowment once they demonstratse potential for success and sustainability. OLLI programs provide lectures and events to older adults who have a thirsg for knowledgeand community. The classeas are designed for adults age 55 and but the Sierra program accepts anyadult student.
Coursee are offered at each of the Sierra College campuses and at various communitty sites throughout Placer and Nevada Sierra College’s OLLI noncredigt offerings are tuition-free. Additional topics are offered throughyClub OLLI, where annual membership fees are $35. As the Busines Journal reported in a feature on localp OLLI programsin 2007, other OLLI programs can be found at California State University Sacramento and at the UC Davis Much of the increased demaned for OLLIs and similar lifelong learnint programs can be attributed to the growing ranks of older Americans.
Friday, March 18, 2011
Tuesday, March 15, 2011
Sunday, March 13, 2011
Menswear store Harleys moving to Lakewood Building - Washington Business Journal:
http://wildlifeskulls.com/goose-hunting-in-colorado-how-i-got-addicted.html
Owner Tim Ryan had said late in 2008 that he was planning to remodel and cut 50 percenr ofthe store’s floor spac at 4009 N. Oakland Ave. However, Ryan announces Tuesday the store will relocate toa 4,100-square-foot space in the Lakewoods Building, 3575 N. Oakland Ave., in Ryan, who owns Harleys with his wife, said he wanted to stay in “This is our home and we are deeplyg committed tothe community,” he Ryan said one of the advantages of the new site is off-streeg parking. The Lakewood Building, a mixed-use residential/commerciall property constructedin 1962, is undergoing a $1.2 million The building is owned by Garrett McIntosh.
Harleyz has contracted with architect Stephen Bollingbroke of Development Collaborativee Limited in Mequon to do aninteriotr buildout. The village of Shorewood providec financial incentives to both the building owner and Harleys to improve the facadwe and interior space of theLakewood Building.
Owner Tim Ryan had said late in 2008 that he was planning to remodel and cut 50 percenr ofthe store’s floor spac at 4009 N. Oakland Ave. However, Ryan announces Tuesday the store will relocate toa 4,100-square-foot space in the Lakewoods Building, 3575 N. Oakland Ave., in Ryan, who owns Harleys with his wife, said he wanted to stay in “This is our home and we are deeplyg committed tothe community,” he Ryan said one of the advantages of the new site is off-streeg parking. The Lakewood Building, a mixed-use residential/commerciall property constructedin 1962, is undergoing a $1.2 million The building is owned by Garrett McIntosh.
Harleyz has contracted with architect Stephen Bollingbroke of Development Collaborativee Limited in Mequon to do aninteriotr buildout. The village of Shorewood providec financial incentives to both the building owner and Harleys to improve the facadwe and interior space of theLakewood Building.
Thursday, March 10, 2011
Survey: Houston not as sweaty as San Antonio, Dallas - Houston Business Journal:
tulusenoveb.blogspot.com
Houston was named the No. 5 sweatiest following San Antonioat No. 2 and Dallas at No. 4. Old Spicd estimated that the three along with list rankersEl Waco, Austin and Corpus produce more than 1.3 million gallons of sweat each summerf — enough to fill the 400,000-gallon Dolphin Bay at the Texasd State Aquarium more than three times. Phoenixx took the “Undisputed Sweatiesrt City” prize for the fifth year in a row thanke to its average summer temperature of 94 degrees and the average residen sweat productionof 27.7 ouncesd of sweat per hour enough to fill more than two soda Las Vegas was at No. 3.
The Sweatiestr Cities rankings are based on computer simulations of the amount of swea a person of average height and weight would produce walkingv around for an hour in averagssummer temperatures, based on historical weathed data for each city during July and August from 2001 to 2008.
Houston was named the No. 5 sweatiest following San Antonioat No. 2 and Dallas at No. 4. Old Spicd estimated that the three along with list rankersEl Waco, Austin and Corpus produce more than 1.3 million gallons of sweat each summerf — enough to fill the 400,000-gallon Dolphin Bay at the Texasd State Aquarium more than three times. Phoenixx took the “Undisputed Sweatiesrt City” prize for the fifth year in a row thanke to its average summer temperature of 94 degrees and the average residen sweat productionof 27.7 ouncesd of sweat per hour enough to fill more than two soda Las Vegas was at No. 3.
The Sweatiestr Cities rankings are based on computer simulations of the amount of swea a person of average height and weight would produce walkingv around for an hour in averagssummer temperatures, based on historical weathed data for each city during July and August from 2001 to 2008.
Tuesday, March 8, 2011
G Line: Perfectly Tailored - Autochannel (press release)
erofeyporgrinin.blogspot.com
AutoSpies.com | G Line: Perfectly Tailored Autochannel (press release) ROLLE, SWITZERLAND â€" March 8, 2011: Comprising saloon, coupé and convertible body styles, rear-wheel-drive or » |
Saturday, March 5, 2011
Thursday, March 3, 2011
Bio bucks - The Business Journal of the Greater Triad Area:
llrx-royce.blogspot.com
Peter Ferris, president of medical devics manufacturer Charter Medicalin Winston-Salem, offers one example. Sure, he’ s worried about the economy, but he also sees opportunitiez in stem cell research that are increasing alonfg with demand for sturdy plastic storage containers to replacse expensive steel containers in thebiopharmaceutical industry. Charter, whicg has traditionally focused on blood transfusion device s andfiltration media, stands to profit from those opportunities and if it’s ready.
So despitw the caution demanded by theprecariouss economy, Ferris’ company is investing heavily in research and developmentr and in the infrastructure needed to support it, such as a sizeabl e expansion under way now of the “clean at its Westpoint Boulevard where about 100 employees work. “That’s being driven by new productg developmentand R&D, and by wanting to go into a broadeer range of products,” Ferris said. He declined to give specifixc figures, but he said the company is spending more on capitap projects this year than in the past fiveyearsx combined, and it is also investinyg in research staff expertise.
“We’ve adde five engineers in the past 18 For a companyour size, that’s pretty Ferris said. One of the results is a new product launcheclast November, Cell-Freeze, a cryogenic storage container for stem No line-item expense, including R&D, is completely immune from the effectws of the recession, but high-tech firms in the Triac and around the country are tryiny to stay as far out on the cuttinf edge of their industries as possible, hoping innovation can provide some shelter from the curreny storm and pay off handsomelyt when the rebound comes. A Wall Street Journal analysix of the 28largest R&D-heavy firms nationwided found research spending down by 0.
7 percenf in the last quarter of 2008, even though revenues were down 7.7 Most of the tech firm in the Triad don’t publiclhy release such data. But several, especiallt those in the life sciences where the research process can take are keeping up or increasin gtheir pace. Winston-Salem-based , for example, increasef its R&D spending by about $800,000 to $10.6 million in the fourth quarter, compared to a year The company has several potentiapl drugs aimed at diseases of the centrao nervous system in clinical and at this point generatew most of its revenue from researchy partnerships with big pharma companies like GlaxoSmithKlinweand AstraZeneca.
It’s a similar story at High Point-basef Pharma, which also is developing drug candidates in partnershilp with Pfizerand others. TransTech is privatelu held and Chief Financial Officef Steve Holcombe declined to givespecific figures, but he said TransTechu has not been cutting back its research. “The wholre pharma industry is basedon R&D,” Holcombe said. “Our revenuer model is based on finding something and then sellinbg it orlicensing it, so we’re only goin g to be as successful as the drugs we’rwe working on.
” At Greensboro-based Novartis Animal Health, Vice President of Research and Development Gary Boschu said his budget is tied more closely to the company’ss long-term outlook than to its quarter-to-quarter results or those of its Swissd parent company, That outlook is strong, Bosch said, so R&s spending is steady. He declined to shar figures for Novartis AnimalHealth specifically, but Novarti s Corp. overall saw researcg spending decline by just a fractiomn in the fourth quarter of from $1.85 billion a year earlier to $1.
83 Bosch wouldn’t say how many of Novartis Animal Health’zs 220 local employees are involved in but he said his goal is to increaser R&D spending as a percentage of sales over One key to making that investment worthwhile in any kind of economyt is putting an emphasis on moving products with commercial potentialp to the finish line quickly. “You have to have a long-terj outlook,” Bosch said. “But you also have to be sure that the productas you have that are close to market are onesthat you’rer concentrating on getting all the way through the process.
” For some Tria d tech firms, recessionary R&D becomes a lesson in doing more with That’s the case for Greensboro wirelesws chip maker , which has been hit hard by the drop in demandc for cell phones and has had to let go about 600 local employees over the past year. The layoffs were part of an overallp effort to cut expensesthat didn’t spars R&D. Spending dropped noticeably in the quarter endingin December, from $53.9 million a year earlierd to $38.6 million.
Executive Vice President JerrhyNeal couldn’t share any R& spending numbers from the March quarte before the company formally reports them later this But he said the drop in spending does not signifu a reduced emphasis on He said, in fact, the company planw to introduce more than 100 new products this the most in any year in its RF Micro is doing so by being more Neal said. The company is in the midst of an effort toboost “engineering velocity” by streamlinint communications between far-flung scientists and consolidatinbg various databases so all researchers can have access to the same technical data at the same time a “single point of truth,” Neal called it.
“The lifeblooe of our business is the introduction of new andinnovativre products,” Neal said. “We’re going to be able to do more of atlower costs.”
Peter Ferris, president of medical devics manufacturer Charter Medicalin Winston-Salem, offers one example. Sure, he’ s worried about the economy, but he also sees opportunitiez in stem cell research that are increasing alonfg with demand for sturdy plastic storage containers to replacse expensive steel containers in thebiopharmaceutical industry. Charter, whicg has traditionally focused on blood transfusion device s andfiltration media, stands to profit from those opportunities and if it’s ready.
So despitw the caution demanded by theprecariouss economy, Ferris’ company is investing heavily in research and developmentr and in the infrastructure needed to support it, such as a sizeabl e expansion under way now of the “clean at its Westpoint Boulevard where about 100 employees work. “That’s being driven by new productg developmentand R&D, and by wanting to go into a broadeer range of products,” Ferris said. He declined to give specifixc figures, but he said the company is spending more on capitap projects this year than in the past fiveyearsx combined, and it is also investinyg in research staff expertise.
“We’ve adde five engineers in the past 18 For a companyour size, that’s pretty Ferris said. One of the results is a new product launcheclast November, Cell-Freeze, a cryogenic storage container for stem No line-item expense, including R&D, is completely immune from the effectws of the recession, but high-tech firms in the Triac and around the country are tryiny to stay as far out on the cuttinf edge of their industries as possible, hoping innovation can provide some shelter from the curreny storm and pay off handsomelyt when the rebound comes. A Wall Street Journal analysix of the 28largest R&D-heavy firms nationwided found research spending down by 0.
7 percenf in the last quarter of 2008, even though revenues were down 7.7 Most of the tech firm in the Triad don’t publiclhy release such data. But several, especiallt those in the life sciences where the research process can take are keeping up or increasin gtheir pace. Winston-Salem-based , for example, increasef its R&D spending by about $800,000 to $10.6 million in the fourth quarter, compared to a year The company has several potentiapl drugs aimed at diseases of the centrao nervous system in clinical and at this point generatew most of its revenue from researchy partnerships with big pharma companies like GlaxoSmithKlinweand AstraZeneca.
It’s a similar story at High Point-basef Pharma, which also is developing drug candidates in partnershilp with Pfizerand others. TransTech is privatelu held and Chief Financial Officef Steve Holcombe declined to givespecific figures, but he said TransTechu has not been cutting back its research. “The wholre pharma industry is basedon R&D,” Holcombe said. “Our revenuer model is based on finding something and then sellinbg it orlicensing it, so we’re only goin g to be as successful as the drugs we’rwe working on.
” At Greensboro-based Novartis Animal Health, Vice President of Research and Development Gary Boschu said his budget is tied more closely to the company’ss long-term outlook than to its quarter-to-quarter results or those of its Swissd parent company, That outlook is strong, Bosch said, so R&s spending is steady. He declined to shar figures for Novartis AnimalHealth specifically, but Novarti s Corp. overall saw researcg spending decline by just a fractiomn in the fourth quarter of from $1.85 billion a year earlier to $1.
83 Bosch wouldn’t say how many of Novartis Animal Health’zs 220 local employees are involved in but he said his goal is to increaser R&D spending as a percentage of sales over One key to making that investment worthwhile in any kind of economyt is putting an emphasis on moving products with commercial potentialp to the finish line quickly. “You have to have a long-terj outlook,” Bosch said. “But you also have to be sure that the productas you have that are close to market are onesthat you’rer concentrating on getting all the way through the process.
” For some Tria d tech firms, recessionary R&D becomes a lesson in doing more with That’s the case for Greensboro wirelesws chip maker , which has been hit hard by the drop in demandc for cell phones and has had to let go about 600 local employees over the past year. The layoffs were part of an overallp effort to cut expensesthat didn’t spars R&D. Spending dropped noticeably in the quarter endingin December, from $53.9 million a year earlierd to $38.6 million.
Executive Vice President JerrhyNeal couldn’t share any R& spending numbers from the March quarte before the company formally reports them later this But he said the drop in spending does not signifu a reduced emphasis on He said, in fact, the company planw to introduce more than 100 new products this the most in any year in its RF Micro is doing so by being more Neal said. The company is in the midst of an effort toboost “engineering velocity” by streamlinint communications between far-flung scientists and consolidatinbg various databases so all researchers can have access to the same technical data at the same time a “single point of truth,” Neal called it.
“The lifeblooe of our business is the introduction of new andinnovativre products,” Neal said. “We’re going to be able to do more of atlower costs.”
Subscribe to:
Posts (Atom)